Is Clindamycin Phosphate Injection (Cleocin Phosphate) in shortage?
Yes. Clindamycin Phosphate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why it’s in shortage
- Demand increase for the drug
- Discontinuation of the manufacture of the drug
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)
Maker contact: 888-229-0001
- Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)
Estimated recovery: October 2026
Maker contact: 888-229-0001
- Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)
Estimated recovery: November 2026
Maker contact: 888-229-0001
- Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)
Maker contact: 888-229-0001
- Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)
Maker contact: 888-229-0001
- Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)
Maker contact: 888-229-0001
- Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)
Maker contact: 800-533-4535
- Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)
Next Delivery and Estimated Recovery: December 2028 More from the maker
Maker contact: 800-533-4535
- Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)
Maker contact: 800-533-4535
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)
Maker contact: 800-525-8747
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)
Maker contact: 800-525-8747
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)
Maker contact: 800-525-8747
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)
Selling through remaining short-dated inventory (Dec 2026).
Maker contact: 866-625-1618
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)
Discontinuation of the manufacture of the drug
Maker contact: 866-625-1618
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)
Selling through remaining short-dated inventory (Dec 2026).
Maker contact: 866-625-1618
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)
Civica Label
Maker contact: 800-525-8747
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)
Civica Label
Maker contact: 800-525-8747
- Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Clindamycin Phosphate Injection:
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro
- MCKESSON CORPORATION recalls CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic
- Pfizer Inc. recalls Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia
- Pfizer Inc. recalls Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia &
- Pfizer Inc. recalls Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia &
- L. Perrigo Company recalls Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo, Yeruham, Israel,
- Pharmacia & Upjohn LLC recalls Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL)
Clindamycin Phosphate Injection shortage questions
Is Clindamycin Phosphate Injection (Cleocin Phosphate) in shortage?
Yes. Clindamycin Phosphate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why is there a Clindamycin Phosphate Injection shortage?
FDA records the reason as: Demand increase for the drug; Discontinuation of the manufacture of the drug.
What should I do if I can’t get Clindamycin Phosphate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.